GW Pharma fiscal Q1 top line up 179%; cash consumption up 65%

|About: GW Pharmaceuticals plc (GWPH)|By:, SA News Editor

GW Pharmaceuticals (NASDAQ:GWPH) fiscal Q1 results ($M): Revenue: 7.7 (+178.8%).

Net loss: (63.3) (-201.3%); loss/share: (0.24) (-188.5%); cash consumption: (53.3) (-64.6%).

Data from Phase 3 tuberous sclerosis study and second Phase 3 in Dravet syndrome expected in H2.

Subscribe for full text news in your inbox